Research Analysts’ Updated EPS Estimates for February 12th (ACCD, ACLS, AMED, AN, APTO, ARVN, AVXL, BCAX, CLGN, CLMT)

Research Analysts’ updated eps estimates for Wednesday, February 12th:

Accolade (NASDAQ:ACCD) had its equal weight rating reiterated by analysts at Stephens. The firm currently has a $7.03 target price on the stock.

Axcelis Technologies (NASDAQ:ACLS) had its hold rating reaffirmed by analysts at Needham & Company LLC.

Amedisys (NASDAQ:AMED) had its equal weight rating reissued by analysts at Stephens. The firm currently has a $101.00 target price on the stock.

AutoNation (NYSE:AN) had its buy rating reiterated by analysts at Guggenheim.

Aptose Biosciences (NASDAQ:APTO) (TSE:APS) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $2.00 price target on the stock.

Arvinas (NASDAQ:ARVN) had its buy rating reissued by analysts at Guggenheim. The firm currently has a $57.00 target price on the stock.

Arvinas (NASDAQ:ARVN) had its outperform rating reissued by analysts at BMO Capital Markets. BMO Capital Markets currently has a $82.00 target price on the stock, down from their previous target price of $88.00.

Anavex Life Sciences (NASDAQ:AVXL) had its buy rating reissued by analysts at D. Boral Capital. They currently have a $46.00 target price on the stock.

Bicara Therapeutics (NASDAQ:BCAX) had its outperform rating reiterated by analysts at Wedbush. They currently have a $31.00 price target on the stock.

CollPlant Biotechnologies (NASDAQ:CLGN) had its buy rating reiterated by analysts at D. Boral Capital. They currently have a $14.00 price target on the stock.

Calumet Specialty Products Partners (NASDAQ:CLMT) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $33.00 price target on the stock.

Coty (NYSE:COTY) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. The firm currently has a $13.00 target price on the stock.

Capri (NYSE:CPRI) had its buy rating reissued by analysts at Guggenheim. The firm currently has a $30.00 price target on the stock.

Ceragon Networks (NASDAQ:CRNT) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $6.00 target price on the stock.

CRISPR Therapeutics (NASDAQ:CRSP) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $84.00 price target on the stock.

DoorDash (NASDAQ:DASH) had its outperform rating reissued by analysts at BMO Capital Markets. BMO Capital Markets currently has a $240.00 price target on the stock, up from their previous price target of $180.00.

DoorDash (NASDAQ:DASH) had its neutral rating reaffirmed by analysts at Piper Sandler. They currently have a $210.00 target price on the stock, up from their previous target price of $160.00.

DoubleDown Interactive (NASDAQ:DDI) had its outperform rating reaffirmed by analysts at Wedbush. They currently have a $21.00 price target on the stock.

Edison International (NYSE:EIX) had its neutral rating reissued by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $72.00 price target on the stock.

Evolent Health (NYSE:EVH) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $15.00 price target on the stock.

Edwards Lifesciences (NYSE:EW) had its outperform rating reissued by analysts at Royal Bank of Canada. The firm currently has a $85.00 target price on the stock.

Exelixis (NASDAQ:EXEL) had its buy rating reiterated by analysts at Guggenheim. They currently have a $42.00 price target on the stock.

Exelixis (NASDAQ:EXEL) had its equal weight rating reaffirmed by analysts at Stephens. The firm currently has a $29.00 price target on the stock.

JFrog (NASDAQ:FROG) had its overweight rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $38.00 price target on the stock.

GlobalFoundries (NASDAQ:GFS) had its outperform rating reiterated by analysts at Wedbush. The firm currently has a $60.00 price target on the stock.

Gilead Sciences (NASDAQ:GILD) had its hold rating reaffirmed by analysts at Needham & Company LLC.

Hovnanian Enterprises (NYSE:HOV) had its underperform rating reaffirmed by analysts at Zelman & Associates.

Humana (NYSE:HUM) had its neutral rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $290.00 price target on the stock.

Humana (NYSE:HUM) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $283.00 target price on the stock.

IMAX (NYSE:IMAX) had its outperform rating reiterated by analysts at Wedbush. Wedbush currently has a $32.00 target price on the stock.

IN8bio (NASDAQ:INAB) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $8.00 price target on the stock.

IPG Photonics (NASDAQ:IPGP) had its hold rating reaffirmed by analysts at Needham & Company LLC.

Kairos Pharma (NYSEAMERICAN:KAPA) had its buy rating reaffirmed by analysts at D. Boral Capital. The firm currently has a $9.00 price target on the stock.

Kelly Services (NASDAQ:KELYA) had its outperform rating reaffirmed by analysts at Barrington Research. They currently have a $25.00 target price on the stock.

Lyft (NASDAQ:LYFT) had its hold rating reiterated by analysts at Needham & Company LLC.

Lyft (NASDAQ:LYFT) had its overweight rating reissued by analysts at Piper Sandler. They currently have a $18.00 target price on the stock, down from their previous target price of $23.00.

Masco (NYSE:MAS) had its sector perform rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $74.00 target price on the stock.

Medtronic (NYSE:MDT) had its hold rating reaffirmed by analysts at Needham & Company LLC.

Merus (NASDAQ:MRUS) had its buy rating reiterated by analysts at Guggenheim.

NIKE (NYSE:NKE) had its buy rating reiterated by analysts at Guggenheim. The firm currently has a $110.00 target price on the stock.

Orion Energy Systems (NASDAQ:OESX) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $3.00 price target on the stock.

Onestream (NASDAQ:OS) had its buy rating reissued by analysts at Guggenheim. Guggenheim currently has a $35.00 target price on the stock.

Onestream (NASDAQ:OS) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $38.00 target price on the stock.

Proficient Auto Logistics (NASDAQ:PAL) had its outperform rating reissued by analysts at Barrington Research. Barrington Research currently has a $15.00 target price on the stock.

Pamt (NASDAQ:PAMT) had its equal weight rating reissued by analysts at Stephens. They currently have a $19.00 target price on the stock.

Palo Alto Networks (NASDAQ:PANW) had its overweight rating reiterated by analysts at Cantor Fitzgerald. They currently have a $223.00 price target on the stock.

Palo Alto Networks (NASDAQ:PANW) had its hold rating reaffirmed by analysts at Westpark Capital. Westpark Capital currently has a $196.40 target price on the stock.

PG&E (NYSE:PCG) had its overweight rating reissued by analysts at JPMorgan Chase & Co.. They currently have a $22.00 price target on the stock.

Restaurant Brands International (NYSE:QSR) (TSE:QSR) had its buy rating reaffirmed by analysts at TD Securities. TD Securities currently has a $70.00 target price on the stock.

RCI Hospitality (NASDAQ:RICK) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $98.00 target price on the stock.

Rallybio (NASDAQ:RLYB) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $5.00 price target on the stock.

Sage Therapeutics (NASDAQ:SAGE) had its neutral rating reaffirmed by analysts at HC Wainwright. They currently have a $12.00 price target on the stock, down from their previous price target of $14.00.

Sage Therapeutics (NASDAQ:SAGE) had its hold rating reaffirmed by analysts at Needham & Company LLC.

Sage Therapeutics (NASDAQ:SAGE) had its neutral rating reaffirmed by analysts at Wedbush. The firm currently has a $6.00 price target on the stock.

Shopify (NYSE:SHOP) (TSE:SHOP) had its neutral rating reissued by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $120.00 price target on the stock.

Super Micro Computer (NASDAQ:SMCI) had its outperform rating reissued by analysts at Northland Securities. The firm currently has a $57.00 price target on the stock, up from their previous price target of $54.00.

STAAR Surgical (NASDAQ:STAA) had its hold rating reiterated by analysts at Needham & Company LLC.

STAAR Surgical (NASDAQ:STAA) had its equal weight rating reiterated by analysts at Stephens. Stephens currently has a $28.00 target price on the stock.

SpringWorks Therapeutics (NASDAQ:SWTX) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $74.00 price target on the stock.

Molson Coors Beverage (NYSE:TAP) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $72.00 price target on the stock.

Tesla (NASDAQ:TSLA) had its sell rating reiterated by analysts at Glj Research. Glj Research currently has a $24.86 price target on the stock.

Tigo Energy (NASDAQ:TYGO) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $3.00 price target on the stock.

Upstart (NASDAQ:UPST) had its overweight rating reaffirmed by analysts at Piper Sandler. Piper Sandler currently has a $105.00 target price on the stock, up from their previous target price of $85.00.

UroGen Pharma (NASDAQ:URGN) had its buy rating reiterated by analysts at D. Boral Capital. D. Boral Capital currently has a $25.00 price target on the stock.

Unitil (NYSE:UTL) had its neutral rating reaffirmed by analysts at Guggenheim. The firm currently has a $55.00 price target on the stock.

Wolverine World Wide (NYSE:WWW) had its market perform rating reissued by analysts at Telsey Advisory Group. The firm currently has a $23.00 target price on the stock.

Yext (NYSE:YEXT) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $10.00 price target on the stock.

Zillow Group (NASDAQ:Z) had its outperform rating reissued by analysts at Wedbush. They currently have a $100.00 target price on the stock.

Zillow Group (NASDAQ:Z) had its hold rating reissued by analysts at Needham & Company LLC.

Zillow Group (NASDAQ:ZG) had its overweight rating reiterated by analysts at Stephens. The firm currently has a $73.00 price target on the stock.

Zillow Group (NASDAQ:ZG) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $88.00 target price on the stock.